Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
QuintilesIMS
Covington
Argus Health
McKinsey
US Department of Justice
Medtronic
Chubb

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017601

« Back to Dashboard

NDA 017601 describes OPTIMINE, which is a drug marketed by Schering and is included in one NDA. Additional details are available on the OPTIMINE profile page.

The generic ingredient in OPTIMINE is azatadine maleate. There are two drug master file entries for this compound. Additional details are available on the azatadine maleate profile page.
Summary for 017601
Tradename:OPTIMINE
Applicant:Schering
Ingredient:azatadine maleate
Patents:0
Therapeutic Class:Respiratory Tract Agents

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength1MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Expired US Patents for NDA 017601

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering OPTIMINE azatadine maleate TABLET;ORAL 017601-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Schering OPTIMINE azatadine maleate TABLET;ORAL 017601-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Federal Trade Commission
McKesson
Boehringer Ingelheim
Healthtrust
Mallinckrodt
QuintilesIMS
Citi
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.